Ezetimibe and Simvastatin
- Product NDC
- 62559-703
- 11-digit product format
- 625590703
- Labeler code
- 62559
- Product ID
- 62559-703_61c89be9-44b0-42ca-bedd-1c0b65662757
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ezetimibe and Simvastatin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- ANI Pharmaceuticals, Inc.
- Application
- ANDA208831
- Marketing category
- ANDA
- Marketing start
- 2018-09-24
- Marketing end
- 2023-03-31
- Substance
- EZETIMIBE; SIMVASTATIN
- Active strength
- 10 mg/1; mg/1
- Pharmacologic classes
- Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 62559-703-30 | 62559070330 | 30 TABLET in 1 BOTTLE (62559-703-30) | 30 tablet | 2018-09-24 | 0000-00-00 | No | No | Current |
| 62559-703-90 | 62559070390 | 90 TABLET in 1 BOTTLE (62559-703-90) | 90 tablet | 2018-09-24 | 0000-00-00 | No | No | Current |